• Aspira Women’s Health appointed John Strahley as chief financial officer, effective April 27, 2026.
• Role also includes chief accounting officer duties.
• Strahley previously served as CFO at several life science companies, including IsoPlexis.
• Earlier roles included managing director at Ironwood Capital.
• Brian Hungerford exited CFO role as consulting agreement terminated April 26, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspira Women's Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000926617-26-000029), on April 30, 2026, and is solely responsible for the information contained therein.